TrialJAMA network open2026

Surveillance vs Standard Surgery and Cost-Effectiveness After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Secondary Analysis of a Randomized Clinical Trial.

Sanjiv S G Gangaram Panday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.